comparemela.com

Page 3 - Ronit Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vasta Platform (NASDAQ:VSTA) Raised to Hold at Zacks Investment Research

Vasta Platform (NASDAQ:VSTA – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a note issued to investors on Wednesday, Zacks.com reports. According to Zacks, “Vasta Platform Limited is an education company principally in Brazil powered by technology, providing end-to-end educational and digital solutions which cater to […]

Vasta Platform Limited (NASDAQ:VSTA) Short Interest Down 53 4% in May

Vasta Platform Limited (NASDAQ:VSTA – Get Rating) saw a large drop in short interest during the month of May. As of May 15th, there was short interest totalling 193,600 shares, a drop of 53.4% from the April 30th total of 415,600 shares. Approximately 1.1% of the shares of the company are short sold. Based on […]

Super Group (NYSE:SGHC) Rating Lowered to Hold at Benchmark

Super Group (NYSE:SGHC – Get Rating) was downgraded by research analysts at Benchmark from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday, Briefing.com reports. A number of other equities research analysts have also recently issued reports on SGHC. Canaccord Genuity Group started coverage on shares of Super […]

Super Group Limited (NYSE:SGHC) Receives Average Rating of Buy from Analysts

Shares of Super Group Limited (NYSE:SGHC – Get Rating) have been assigned a consensus rating of “Buy” from the six brokerages that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the […]

Nuvectis Pharma, Inc (NASDAQ:NVCT) Expected to Announce Earnings of -$0 24 Per Share

Wall Street brokerages forecast that Nuvectis Pharma, Inc. (NASDAQ:NVCT – Get Rating) will report earnings of ($0.24) per share for the current quarter, according to Zacks Investment Research. Zero analysts have provided estimates for Nuvectis Pharma’s earnings. The lowest EPS estimate is ($0.27) and the highest is ($0.20). The business is scheduled to announce its […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.